Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

0.00%

34.5¢ botanix pharmaceuticals ltd

The clarification around a CR is great news. Nice to hear that...

First 457 Last

Share
Profile

Follow
procrastinator

930 Posts.

111

21/06/19

16:35

Post #: 39179161
Share

Originally posted by bernsta ↑

So managed to have a nice conversation with Matt this afternoon - i scribbled down what I could, brief update below whilst some is fresh in my head and in front of me:

My questions and key takeaways:

Q) If BTX1801 works on animal wounds, would we expect it work on humans ?

A) Does not foresee any issues at all as the models are translated into human efficacy and the bugs are done in real life situations with the anti-microbal effect. Essentially the Phase 1 and 1B studies are already completed here as they are replicating the studies with AD and Acne. The bacteria forms no resistance. Indicated that they somewhat stumbled upon this little beauty and thinks this may actually be bigger then other products in terms of value. Mentioned a huge market cap alone for this product when compared to NXS valuation.

Q) Are we looking at a CR?

A) He could not have said NO any clearer - he said many brokers have approached him regarding this basically seeking a 20% placement and he's told them to buy on marke (and he admitted they needed the cash back then). With the R & D rebate and the cash on hand to come they are fully funded to phase 2 trials. He said he will let the results decide the price. He feels this put a strangle on the share price in the past, which is why it hasn't run as much as it should have. He wants the price to run and the data to do the talking.

Q) How did Vince come over?

A) He did a good 6-12 months due diligence prior - BOT did approach him, but scoring him is a huge bonus for the company. 12 months ago big pharma had no idea on CBD. BOT essentially has a 3 year head start on anyone in this space.

Q) Trials for phase 2 studies running on time ?

A) No issues with timing, all running on time and as expected, results expected to be released next quarter as mentioned. Going very well as planned.

Q) Are big pharma sniffing?

A) Has had many meetings with big pharma already. They all ask the same q'n - how do you do what you do? He laughs in response. Will let data do the talking. He plans to be back in 6-8 weeks and regularly come to Aus from now on.

There is more - but wanted to provide a brief update on key issues - he's obviously having a very big day with meetings. Was very nice of him to give me half an hour.

This company is extremely easy to get in contact with. Matt is extremely accommodating and I encourage holders to get in touch.

Have a fantastic weekend.

Expand

The clarification around a CR is great news. Nice to hear that he is going to let the share price run, its about time he did.
Really well done @bernsta, thanks heaps for sharing with community.

BOT Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

PGD

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

LYC

Lynas eyes first dysprosium, terbium HREE production in CY25

PDN

Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance

There are more pages in this discussion • 166 more messages in this thread...

First 457 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 34.5¢		Change 0.000(0.00%)		Mkt cap ! $543.4M

Open	High	Low	Value	Volume
34.0¢	34.5¢	33.5¢	$426.6K	1.255M

Buyers (Bids)

No.	Vol.	Price($)
7	251993	34.0¢

Sellers (Offers)

Price($)	Vol.	No.
34.5¢	290807	9

View Market Depth

No.	Vol.	Price($)
5	109736	0.340
14	622772	0.335
23	861061	0.330
8	963366	0.325
22	620552	0.320

Price($)	Vol.	No.
0.345	174897	6
0.350	663057	4
0.355	235085	6
0.360	528758	7
0.365	293724	5

Last trade - 10.18am 27/06/2024 (20 minute delay)

BOT (ASX) Chart

The clarification around a CR is great news. Nice to hear that...

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Lynas eyes first dysprosium, terbium HREE production in CY25

Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The clarification around a CR is great news. Nice to hear that...

Top Stories

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Lynas eyes first dysprosium, terbium HREE production in CY25

Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News